Anteris Technologies Global (NASDAQ:AVR) Stock Price Down 5.8% – Here’s Why

Shares of Anteris Technologies Global Corp. (NASDAQ:AVR) were down 5.8% during mid-day trading on Tuesday . The stock traded as low as $8.79 and last traded at $9.06. Approximately 231,645 shares changed hands during trading, a decline of 79% from the average daily volume of 1,125,993 shares. The stock had previously closed at $9.62.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on AVR shares. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $15.00 price objective on shares of Anteris Technologies Global in a report on Friday, March 27th. Wells Fargo & Company started coverage on Anteris Technologies Global in a report on Wednesday, March 11th. They set an “overweight” rating and a $16.00 price objective on the stock. Wall Street Zen raised Anteris Technologies Global from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Finally, Barclays raised their price objective on Anteris Technologies Global from $17.00 to $18.00 and gave the stock an “overweight” rating in a report on Friday, May 15th. Four equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Anteris Technologies Global presently has a consensus rating of “Moderate Buy” and a consensus target price of $16.00.

Anteris Technologies Global Trading Down 1.0%

The stock has a fifty day simple moving average of $6.34 and a two-hundred day simple moving average of $5.61. The company has a market cap of $853.69 million, a PE ratio of -3.93 and a beta of 1.32.

Anteris Technologies Global (NASDAQ:AVR) last announced its quarterly earnings data on Tuesday, May 12th. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). Anteris Technologies Global had a negative net margin of 5,148.78% and a negative return on equity of 124.76%. The business had revenue of $0.49 million during the quarter, compared to analysts’ expectations of $0.77 million. During the same period in the prior year, the firm posted ($0.61) EPS. As a group, equities research analysts anticipate that Anteris Technologies Global Corp. will post -1.14 EPS for the current fiscal year.

Institutional Investors Weigh In On Anteris Technologies Global

Hedge funds and other institutional investors have recently modified their holdings of the stock. Russell Investments Group Ltd. lifted its position in shares of Anteris Technologies Global by 76.9% during the 3rd quarter. Russell Investments Group Ltd. now owns 6,536 shares of the company’s stock valued at $29,000 after acquiring an additional 2,841 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of Anteris Technologies Global during the 1st quarter worth approximately $32,000. BNP Paribas Financial Markets raised its position in shares of Anteris Technologies Global by 83.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 9,469 shares of the company’s stock worth $43,000 after purchasing an additional 4,302 shares during the last quarter. Bank of America Corp DE raised its position in shares of Anteris Technologies Global by 35.7% during the 3rd quarter. Bank of America Corp DE now owns 10,631 shares of the company’s stock worth $48,000 after purchasing an additional 2,798 shares during the last quarter. Finally, Duncan Williams Asset Management LLC acquired a new position in shares of Anteris Technologies Global during the 4th quarter worth approximately $54,000.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.